Cell cycle-dependent tumor necrosis factor apoptosis

Cancer Research

Volumn 56, Issue 7, 1996, Pages 1591-1598

  Shih, Shu Ching ^a   Stutman, Osias ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; RECOMBINANT TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; DOSE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOLID TUMOR;

APOPTOSIS; CELL CYCLE; DNA DAMAGE; DNA REPLICATION; G0 PHASE; G1 PHASE; HUMANS; S PHASE; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029958879     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Carswell, E. A , Old, L J., Kassel, R L , Green, S., Fiore, N., and Williamson, B. An endotoxin-induced serum factor that causes necrosis of tumors Proc. Natl. Acad. Sci. USA, 72: 3666-3670, 1975.
2. Old, L. J. Tumor necrosis factor (TNF). Science (Washington DC), 230: 630-632, 1985.
3. Goeddel, D. V., Aggarwal, B. B., Gray, P. W., Leung, D. W., Nedwin, G. E., Palladino, A. M., Patton, J. S., Pennica, D., Shepard, H. M., Sugarman, B. J , and Wong, G H. W Tumor necrosis factors: gene structure and biological activities. Cold Spring Harbor Symp. Quant. Biol., 51: 597-609, 1986.
4. Beutler, B., and Cerami, A The biology of cachectin/TNF-a primary mediator of the host response. Annu Rev. Immunol., 7: 625-655, 1989.
5. Fiers, W. Tumor necrosis factor: characterization at the molecular, cellular and in vivo level. FEBS Lett., 285: 199-212, 1991.
6. 125I-labeled tumor necrosis factor: specific binding, affinity labeling, and relationship to sensitivity. Proc. Natl. Acad. Sci. USA, 82: 5756-5760, 1985.
7. Brockhaus, M., Schoenfeld, H. J., Schlaeger, E. J., Hunziker, W., Lesslauer, W , and Loetscher, H. Identification of two types of tumor necrosis factor receptor human cell lines by monoclonal antibodies. Proc. Natl. Acad. Sci. USA, 87: 3127-3131, 1990.
8. Smith, C. A., Davis, T , Anderson, D , Solam, L., Beckmann, M. P., Jerzy, R., Dower, S. K., Cosman, D., and Goodwin, R. G. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science (Washington DC), 248: 1019-1022, 1990.
9. Lewis, M., Tartaglia, L. A., Lee, A., Bennett, G. L., Rice, G. C , Wong, G H. W., Chen, E. Y., and Goeddel, D. V. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc. Natl. Acad. Sci. USA, 88: 2830-2834, 1991.
10. Dealtry, G. B., Naylor, M. S., Fiers, W., and Balkwill, F R. DNA fragmentation and cytotoxicity caused by tumor necrosis factor is enhanced by interferon γ. Eur J. Immunol , 17: 689-693, 1987.
11. Rubin, B. Y , Smith, L. J., Hellerman, G. R., Lunn, R. M , Richardson, N K , and Anderson, S. L. Correlation between the anticellular and DNA fragmenting activities of tumor necrosis factor. Cancer Res., 48: 6006-6010, 1989.
12. Woods, K. M., and Chapes, S. K. Three distinct cell phenotypes of TNF-induced cytotoxicity and their relationship to apoptosis J Leukocyte Biol , 53: 37-44, 1993.
13. Laster, S N., Wood, J G , and Gooding, L. R. Tumor necrosis factor can induce both apoptotic and necrotic forms of cell lysis. J. Immunol., 141: 2629-2634, 1988.
14. Murray, A. W. Creative blocks: cell-cycle checkpoint, and feedback controls. Nature (Lond ), 359: 599-604, 1993.
15. Darzynkiewicz, Z., Williamson, B., Carswell, E A , and Old, L J. Cell cycle-specific effects of tumor necrosis factor. Cancer Res., 44: 83-90, 1984.
16. Coffman, F D., Haviland, D. L., Green, M. L , and Ware, C. F Cytotoxicity by tumor necrosis factor is linked cell cycle but does not require DNA synthesis. Growth Factors, 1: 357-364, 1989
17. 1 phase of the cell cycle Cancer Res., 51. 2379-2385, 1991.
18. Lattime, E C , and Stutman, O WEHI-164 clone 2F: in vitro antitumor effects of tumor necrosis factor and γ-interferon. Nat Immun , 11 34-45, 1992
19. Lattime, E. C , Bykowsky, M. J , and Stutman, O. Susceptibility to lysis by natural killer and natural cytotoxic cells is independent of the mitotic stage of the target cell cycle. Cell. Immunol , 100: 79-88, 1986.
20. Hickmann, J. A Apoptosis induced by anticancer drugs. Cancer Metastasis Rev , 11: 121-139, 1992.
21. Gorczyca, W , Gong, J , Ardelt, B. Traganos, F , and Darzynkiewicz, Z. The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Cancer Res., 53: 3186-3192, 1993.
22. 1 controls animal cell growth. Proc Natl Acad. Sci. USA, 76: 4446-4450, 1979.
23. Soprano, K. J., and Cosenza, S C Cell cycle and cell growth control. In: G. S. Stein and J B Lian (eds.), Molecular and Cellular Approaches to the Control of Proliferation and Differentiation, pp. 73-114. New York: Academic Press, 1992.
24. Dietch, A. D , Law, H., and White, R D A stable propidium iodide staining procedure for flow cytometry. J. Histochem. Cytochem , 30: 967-972, 1982
25. Nicoletti, I., Migliorati, G., Pagliacci, M. C , Grignani, F., and Riccardi, C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods, 139: 271-279, 1991.
26. Hernández-Caselles, T , and Stutman, O. Immune functions of tumor necrosis factor. I Tumor necrosis factor induces apoptosis of mouse thymocytes and can also stimulate of inhibit IL-6-induced proliferation depending on the concentration of mitogenic costimulation. J Immunol , 151: 3999-4012, 1993
27. Boehme, S. A , and Lenardo, M. J. Propriocidal apoptosis of mature T lymphocytes occurs at S phase of the cell cycle. Eur. J Immunol., 23: 1552-1560, 1993.
28. Jones, C. L , Simpson, N J., Waryas, V. L., and Pappas, M. G. An inexpensive method of drying multiple agarose gels. BioTechniques, 6. 118-119, 1988.
29. Preston, G. A., Lang, J. E., Maronpot, R. R., and Barrett, J C. Regulation of apoptosis by low serum in cells of different stages of neoplastic progression, enhanced susceptibility after loss of a senescence gene and decreased susceptibility after loss of a tumor suppressor gene. Cancer Res., 54: 4214-4223, 1994.
30. Lindenboim, L., Diamond, R., Rothenberg, E , and Stein, R. Apoptosis induced by serum deprivation of PC12 cells is not preceded by growth arrest and can occur at each phase of the cell cycle. Cancer Res., 55: 1242-1247, 1995.
31. Cohen, J. J., Duke, R. C., Facok, V. A., and Sellins, K. S. Apoptosis and programmed cell death in immunity. Annu. Rev. Immunol., 10: 267-293, 1992.
32. Arends, M. J., Morris, R. G , and Wyllie, A H. Apoptosis. the role of the endonuclease. Am. J Pathol , 136: 593-608, 1990.
33. Duvall, E., and Wyllie, A. H. Death and the cell. Immunol. Today, 7: 115-119, 1986.
34. Lancaster, J. R., Jr., Laster, S. M , and Gooding, L. R. Inhibition of target cell mitochondrial electron transfer by tumor necrosis factor FEBS Lett., 248: 169-174, 1989
35. Laskey, R. A., Fairman, M P., and Blow, J. J. S phase of the cell cycle. Science (Washington DC), 246: 609-614, 1989.
36. Norbury, C , and Nurse, P. Animal cell cycles and their control. Annu. Rev. Biochem., 61: 441-470, 1992.
37. Lazebnik, Y. A., Cole, S., Cooke, C. A., Nelson, W. G., and Earnshaw, W. C. Nuclear events of apoptosis in vitro in cell-free mitotic extracts: a model system for analysis of the active phase of apoptosis J Cell Biol., 123: 7-22, 1993
38. Sen, S., and D'Incalci, M. Apoptosis: biochemical events and relevance to cancer chemotherapy. FEBS Lett., 307: 122-127, 1992.
39. Gavrieli, Y , Sherman, Y , and Ben-Sasson, S A. Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation J Cell Biol., 119. 493-498, 1992.
40. Chapman, R. S , Chresta, C. M., Herberg, A A., Beere, H M , Heer, S., Whetton, A. D., Hickman, J. A., and Dive, C. Further characterisation of the in situ terminal deoxynucleotidyl transferase (TdT) assay for the flow cytometric analysis of apoptosis in drug resistant and drug sensitive leukaemic cells Cytometry, 20 245-256, 1995.
41. Hartwell, L. H., and Weinert, T. A. Checkpoints: controls that ensure the order of cell cycle events. Science (Washington DC), 246: 629-634, 1989.
42. Rittling, S R., Brooks, K. M., Cristofalo, V J., and Baserga, R. Expression of cell cycle-dependent genes in young and senescent WI-38 fibroblasts. Proc. Natl. Acad. Sci. USA, 83. 3316-3320, 1986.
43. Duke, R. C., Cohen, J. J., and Chervenak, R. Differences in target cell DNA fragmentation induced by mouse cytotoxic T lymphocytes and natural killer cells J Immunol., 137: 1442-1447, 1986.
44. Duke, R. C., and Cohen, J. J IL-2 addiction: withdrawal of growth factor activates a suicide program in dependent T cells. Lymphokine Res., 5: 289-299, 1986.
45. Wyllie, A. H. Glucocorticoid induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature (Lond ), 284: 555-556, 1980.
46. Krammer, P. H., Behrmann, I., Daniel, P., Dhein, J., and Debatin, K. M. Regulation of apoptosis in the immune system. Curr. Opin Immunol., 6: 279-289, 1994.
47. Kelly, K., Cochran, B. H., Stiles, C. D., and Leder, P. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell, 35: 603-610, 1983
48. Reich, N. C., and Levine, A J. Growth regulation of a cellular tumour antigen, p53, in nontransformed cells. Nature (Lond), 308: 199-201, 1984
49. Lin, J. X., and Vilcek, J. Tumor necrosis factor and interleukin-1 cause a rapid and transient stimulation of c-fos and c-myc mRNA levels in human fibroblasts. J. Biol. Chem , 262: 11908-11911, 1987.
50. Sherr, C. J. Mammalian G1 Cyclins. Cell, 73: 1059-1065, 1993.
51. Gehr, G., Gentz, R., Brockhaus, M., Loetscher, H., and Lesslauer, W. Both tumor necrosis factor receptor types mediate proliferative signals in human mononuclear cell activation. J. Immunol., 149. 911-917, 1992
52. Heller, R. A., Song, K., Fan, N., and Chang, D. J. The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell, 70: 47-56, 1992.
53. Grell, M., Scheurich, P., Meager, A., and Pfizenmaier, K. TR60 and TR80 tumor necrosis factor (TNF)-receptors can independently mediate cytolysis. Lymphokine Cytokine Res., 12: 143-148, 1993.
54. Bigda, J., Beletsky, I., Bradebusch, C., Varfolomeev, Y , Engelmann, H., Bigda, J., Holtmann, H., and Wallach, D. Dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicity. J. Exp. Med., 180. 445-460, 1994.
55. Clement, M. A , and Stamenkovic, I. Fas and tumor necrosis factor-mediated cell death: similarities and distinctions J Exp. Med , 180: 557-567, 1994.
56. Tartaglia, L. A., Weber, R. F., Figari, I. S., Reynolds, C. Palladino, M. A., and Goeddel, D. V. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acad. Sci. USA, 88: 9292-9296, 1991.